Methyl 4,6,7,8,9,10-hexahydro-2-hydroxy-4-oxopyrido[1,2-a]azepine-1-carboxylate, 95+%, 250mg

2-(4-Bromophenyl)piperidine, 97%, 1g

7,7'-Dimethoxy-[4,4']bi[benzo[1,3]dioxolyl]-5,5'-dicarboxylic acid, 97.0%, 5g

(2-CHLORO-6-METHYLPYRIDIN-4-YL)METHANOL, 95.0%, 2g

BICYCLOHEXYL, 97.0%, 25ml

(S)-2-Amino-3-(o-tolyl)propanoic acid, 95.0%, 10g

3,4-Difluoro-5-ethoxyphenylboronic acid, 95%, 250mg

8-Fluoroquinazoline-2,4(1H,3H)-dione, 95.0%, 5g

(S)-1-TERT-BUTYL 3-METHYL 3-METHOXYPYRROLIDINE-1,3-DICARBOXYLATE, 95.0%, 1g

5-Iodo-1-methyluracil, 98%, 100mg

(5aS,10bR)-2-(2,4,6-Trichlorophenyl)-4,5a,6,10b-tetrahydro-2H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-11-ium tetrafluoroborate, 97.0%, 1g

dimethyl sulfoxide, min 99.5%, for synthesis, 2.5 l, glass packaging

Methyl 2-chloro-3-iodo-4-methylbenzoate, 95%, 1g